Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Biologically-Adapted, Dose-Escalated Accelerated Radiotherapy for Ewing Sarcoma (BEAR)

NCT07188532 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT07188532
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07188532 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Biologically-Adapted, Dose-Escalated Accelerated Radiotherapy for Ewing Sarcoma (BEAR)
Lead sponsor
Mayo Clinic
Phase
Not applicable
Overall status
Recruiting
Start date
December 5, 2025
Completion date
August 25, 2033
Enrollment
170 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

ewing sarcoma, round cell sarcoma with ewsr1-non-ets fusion